Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
Cancer peptide vaccination represents a promising therapeutic approach, but has been hampered by lack of suitable antigens and restricted applicability due to different HLA backgrounds of individual patients. We here introduce a novel warehouse-based concept for composition of personalized peptide v...
Saved in:
Main Authors: | Jonas S. Heitmann, Susanne Jung, Marcel Wacker, Yacine Maringer, Annika Nelde, Jens Bauer, Monika Denk, Naomi Hoenisch-Gravel, Marion Richter, Melek T. Oezbek, Marissa L. Dubbelaar, Tatjana Bilich, Marina Pumptow, Peter Martus, Gerald Illerhaus, Claudio Denzlinger, Francesca Steinbach, Walter-Erich Aulitzky, Martin R. Müller, Daniela Dörfel, Hans–Georg Rammensee, Helmut R. Salih, Juliane S. Walz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1482715/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma
by: Gundram Jung, et al.
Published: (2020-10-01) -
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies
by: Hans-Georg Rammensee, et al.
Published: (2020-05-01) -
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics
by: Julia Velz, et al.
Published: (2025-02-01) -
Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial
by: Klaus Brasso, et al.
Published: (2020-10-01) -
Identification and relative abundance of naturally presented and cross-reactive influenza A virus MHC class I-restricted T cell epitopes
by: Hazem Hamza, et al.
Published: (2024-12-01)